| 发明名称 |
NOVEL MSLN TARGETING DNA VACCINE FOR CANCER IMMUNOTHERAPY |
| 摘要 |
The present invention relates to an attenuated mutant strain of Salmonella comprising a recombinant DNA molecule encoding Mesothelin. In particular, the present invention relates to the use of said attenuated mutant strain of Salmonella in cancer immunotherapy. |
| 申请公布号 |
US2016317634(A1) |
申请公布日期 |
2016.11.03 |
| 申请号 |
US201415105739 |
申请日期 |
2014.12.17 |
| 申请人 |
VAXIMM GMBH MAFINEX-TECHNO-LOGIEZENTRUM |
发明人 |
SPRINGER Marco;LUBENAU Heinz |
| 分类号 |
A61K39/00;C12N1/36;C12R1/42;C12N1/20 |
主分类号 |
A61K39/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An attenuated mutant strain of Salmonella comprising at least one copy of a recombinant DNA molecule comprising an expression cassette encoding Mesothelin (MSLN). |
| 地址 |
Mannheim DE |
